ArticleJournal of thoracic disease2026

Safety, feasibility, and exploratory biomarker findings of bone marrow-derived mesenchymal stromal cells in hospitalized severe COVID-19: a phase I/II randomized trial.

Ying Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.